These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15710740)

  • 1. Secondary prevention of coronary heart disease in the elderly.
    Bulpitt CJ
    Heart; 2005 Mar; 91(3):396-400. PubMed ID: 15710740
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stable ischemic coronary disease--medical therapy or PCI?].
    Mickley H; Egstrup K
    Ugeskr Laeger; 2007 Jun; 169(23):2227. PubMed ID: 17607849
    [No Abstract]   [Full Text] [Related]  

  • 3. Do the current medical and economic times dictate the need for the "polypill"?
    Rifai L; Khan BV
    J Clin Hypertens (Greenwich); 2009 Dec; 11(12):775-6. PubMed ID: 20021541
    [No Abstract]   [Full Text] [Related]  

  • 4. Doxazosin arm of the ALLHAT study discontinued: how equal are antihypertensive drugs? Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial.
    Messerli FH; Grossman E
    Curr Hypertens Rep; 2000 Jun; 2(3):241-2. PubMed ID: 10981155
    [No Abstract]   [Full Text] [Related]  

  • 5. Managing established coronary heart disease.
    Moher M; Schofield T; Weston S; Fullard E
    BMJ; 1997 Jul; 315(7100):69-70. PubMed ID: 9240033
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 7. Summaries for patients. Risk factors and treatment in women with coronary artery disease.
    Ann Intern Med; 2003 Jan; 138(2):I10. PubMed ID: 12529114
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological interventions to manage coronary heart disease.
    Parkinson D
    Nurs Times; 2003 Jul 8-14; 99(27):48-9. PubMed ID: 12882058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention of ischaemic cardiac events.
    Gami A
    Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
    EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
    Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should elderly individuals who frequently nap take beta-blockers and/or aspirin?
    Goldstein MR
    Arch Intern Med; 2000 Mar; 160(5):710; author reply 711-2. PubMed ID: 10724058
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conservative treatment of coronary heart disease--current options].
    Desch S; Schuler G; Niebauer J
    MMW Fortschr Med; 2005 Feb; 147(8):45-7. PubMed ID: 18437860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prevention of coronary heart disease in the elderly.
    Dornbrook-Lavender KA; Roth MT; Pieper JA
    Ann Pharmacother; 2003 Dec; 37(12):1867-76. PubMed ID: 14632542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prevention in coronary heart disease: goal achievement and drug prescribing.
    Giverhaug T; Bruland C; Trovik T
    Pharm World Sci; 2005 Dec; 27(6):472-4. PubMed ID: 16341957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study.
    Vittinghoff E; Shlipak MG; Varosy PD; Furberg CD; Ireland CC; Khan SS; Blumenthal R; Barrett-Connor E; Hulley S;
    Ann Intern Med; 2003 Jan; 138(2):81-9. PubMed ID: 12529088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAD initiative begins at the hospital with medication, lifestyle interventions.
    Clin Resour Manag; 2001 Sep; 2(9):132-5, 129. PubMed ID: 11577511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention of atherothrombotic or cryptogenic stroke.
    Tai WA; Albers GW
    Circulation; 2014 Jan; 129(4):527-31. PubMed ID: 24470474
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary prevention of coronary heart disease in older patients after the national service framework: population based study.
    Ramsay SE; Whincup PH; Lawlor DA; Papacosta O; Lennon LT; Thomas MC; Ebrahim S; Morris RW
    BMJ; 2006 Jan; 332(7534):144-5. PubMed ID: 16401630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular protection and prevention in patients with cardiac conditions and diabetes].
    Charpentier G; Puel J; Steg PG
    Presse Med; 2005 Oct; 34(18):1295-8. PubMed ID: 16269992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients with type 2 diabetes after acute coronary syndromes.
    Bartnik M; Malmberg K; Rydén L
    Diab Vasc Dis Res; 2005 Oct; 2(3):144-54. PubMed ID: 16334596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.